Publication | Open Access

Substitution of the phosphonic acid and hydroxamic acid functionalities of the DXR inhibitor FR900098: An attempt to improve the activity against Mycobacterium tuberculosis

Phosphonic AcidPulmonary TuberculosisHealth SciencesDxr Inhibitor Fr900098MedicineMycobacterium TuberculosisTuberculosisAntibacterial AgentMicrobiologyAntimicrobial CompoundPharmacologyClinical MicrobiologyAntimicrobial ResistanceDrug DiscoveryDrug Resistance